Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 6
2010 115
2011 280
2012 279
2013 331
2014 327
2015 276
2016 293
2017 220
2018 208
2019 211
2020 185
2021 123
2022 15
2023 2
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

2,489 results

Results by year

Filters applied: . Clear all
Page 1
Targeting mTOR for cancer therapy.
Hua H, Kong Q, Zhang H, Wang J, Luo T, Jiang Y. Hua H, et al. J Hematol Oncol. 2019 Jul 5;12(1):71. doi: 10.1186/s13045-019-0754-1. J Hematol Oncol. 2019. PMID: 31277692 Free PMC article. Review.
Rapamycin: one drug, many effects.
Li J, Kim SG, Blenis J. Li J, et al. Cell Metab. 2014 Mar 4;19(3):373-9. doi: 10.1016/j.cmet.2014.01.001. Epub 2014 Feb 6. Cell Metab. 2014. PMID: 24508508 Free PMC article. Review.
mTOR inhibition improves immune function in the elderly.
Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, Huang B, Lonetto MA, Maecker HT, Kovarik J, Carson S, Glass DJ, Klickstein LB. Mannick JB, et al. Sci Transl Med. 2014 Dec 24;6(268):268ra179. doi: 10.1126/scitranslmed.3009892. Sci Transl Med. 2014. PMID: 25540326 Clinical Trial.
TOR-inhibitors as gero-suppressors.
Nikiforov M. Nikiforov M. Aging (Albany NY). 2015 Dec;7(12):1030-1. doi: 10.18632/aging.100869. Aging (Albany NY). 2015. PMID: 26796970 Free PMC article. No abstract available.
Research progress of mTOR inhibitors.
Chen Y, Zhou X. Chen Y, et al. Eur J Med Chem. 2020 Dec 15;208:112820. doi: 10.1016/j.ejmech.2020.112820. Epub 2020 Sep 13. Eur J Med Chem. 2020. PMID: 32966896 Review.
Revisiting mTOR inhibitors as anticancer agents.
Teng QX, Ashar YV, Gupta P, Gadee E, Fan YF, Reznik SE, Wurpel JND, Chen ZS. Teng QX, et al. Drug Discov Today. 2019 Oct;24(10):2086-2095. doi: 10.1016/j.drudis.2019.05.030. Epub 2019 Jun 4. Drug Discov Today. 2019. PMID: 31173912 Review.
Targeting mTOR in Acute Lymphoblastic Leukemia.
Simioni C, Martelli AM, Zauli G, Melloni E, Neri LM. Simioni C, et al. Cells. 2019 Feb 21;8(2):190. doi: 10.3390/cells8020190. Cells. 2019. PMID: 30795552 Free PMC article. Review.
2,489 results